AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32047100 — intervention group
Group type: COMPARATOR
Intervention: No conversations with a doctor about HIV testing
Number of subjects: 699
Study 32047100 — intervention group
Group type: EXPERIMENTAL
Intervention: Age groups
Number of subjects: 699
Study 32047100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual experience
Number of subjects: 699
Study 33526434 — intervention group
Group type: EXPERIMENTAL
Intervention: telephone cognitive-behavioural therapy (tCBT)
Number of subjects: 996
Study 33526434 — intervention group
Group type: COMPARATOR
Intervention: usual care (UC)
Number of subjects: 996
Study 32040141 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient integrated palliative care (PC) administered by a neurologist, social worker, chaplain, and nurse.
Number of subjects: 210
Study 32040141 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone.
Number of subjects: 210
Study 32040141 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient integrated palliative care (PC) at 12 months.
Number of subjects: 210
Study 32040141 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone at 12 months.
Number of subjects: 210
Study 34437944 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Femoroplasty (automated radiographic visualization tool)
Number of subjects: 28
Study 34437944 — intervention group
Group type: COMPARATOR
Intervention: Routine fluoroscopy (Control)
Number of subjects: 28
Study 36102287 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 269
Study 36102287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 34151672 — intervention group
Group type: COMPARATOR
Intervention: Plain Balloon Angioplasty (POBA)
Number of subjects: 301
Study 34151672 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug Coated Balloon (DCB) (Paclitaxel)
Number of subjects: 301
Study 32928798 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to individual practices (WHO Safe Childbirth Checklist)
Number of subjects: 3274
Study 32928798 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct provider care practices
Number of subjects: 3274
Study 32928798 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence to practices
Number of subjects: 3274
Study 35778318 — intervention group
Group type: COMPARATOR
Intervention: Generic prevention materials
Number of subjects: 920
Study 35778318 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision prevention materials (average genetic risk)
Number of subjects: 920
Study 35778318 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision prevention materials (higher genetic risk)
Number of subjects: 920
Study 35778318 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish language materials
Number of subjects: 920
Study 35778318 — intervention group
Group type: EXPERIMENTAL
Intervention: English language materials (precision prevention groups)
Number of subjects: 920
Study 33544653 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise training (45‐55% heart rate reserve)
Number of subjects: 104
Study 33544653 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise training (70‐85% heart rate reserve)
Number of subjects: 104
Study 33544653 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 35927504 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected multistrain probiotics (N = 28) for 12 weeks
Number of subjects: 60
Study 35927504 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 32) for 12 weeks
Number of subjects: 60
Study 36102219 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal metabolic parameters (fasting glucose, insulin, HOMA-IR, leptin)
Number of subjects: 0
Study 36102219 — intervention group
Group type: COMPARATOR
Intervention: Low glycaemic index diet (as part of the ROLO study)
Number of subjects: 0
Study 34165599 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Ventricular Pacing (RP)
Number of subjects: 473
Study 34165599 — intervention group
Group type: COMPARATOR
Intervention: Fast Ventricular Pacing (FP)
Number of subjects: 473
Study 34165599 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective criteria (0-2 criteria)
Number of subjects: 473
Study 32770131 — intervention group
Group type: EXPERIMENTAL
Intervention: Tap water from public drinking fountains
Number of subjects: 0
Study 32770131 — intervention group
Group type: COMPARATOR
Intervention: Filtered water from point-of-use (POU) water dispensers
Number of subjects: 0
Study 35355333 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-control training
Number of subjects: 59
Study 35355333 — intervention group
Group type: COMPARATOR
Intervention: Placebo attention training
Number of subjects: 59
Study 34676743 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-handed jaw thrust technique
Number of subjects: 74
Study 34676743 — intervention group
Group type: COMPARATOR
Intervention: Conventional i-gel insertion
Number of subjects: 74
Study 32609011 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II therapy
Number of subjects: 255
Study 32609011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 35239968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab q12w
Number of subjects: 348
Study 35239968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab q8w
Number of subjects: 348
Study 35239968 — intervention group
Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 348
Study 33292873 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga training (YT)
Number of subjects: 348
Study 34453530 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanation about a hypothetical transition to a biosimilar with companion
Number of subjects: 79
Study 34453530 — intervention group
Group type: COMPARATOR
Intervention: Explanation about a hypothetical transition to a biosimilar alone
Number of subjects: 79
Study 34453530 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support from companions
Number of subjects: 79
Study 34147116 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated chewing gum (5.4 mg/kg)
Number of subjects: 9
Study 34147116 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated chewing gum (2.7 mg/kg)
Number of subjects: 9
Study 34147116 — intervention group
Group type: COMPARATOR
Intervention: Non-caffeinated chewing gum
Number of subjects: 9
Study 36313781 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on CT imaging features of paravertebral muscles
Number of subjects: 149
Study 36313781 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Nomogram model based on radiomics and clinical characteristics
Number of subjects: 149
Study 36313781 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 149
Study 32882693 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 97
Study 32882693 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 97
Study 33355217 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir (LPV/r)
Number of subjects: 19
Study 34152561 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD group (n=108)
Number of subjects: 1826
Study 34152561 — intervention group
Group type: COMPARATOR
Intervention: Non-CVD group (n=1718)
Number of subjects: 1826
Study 34152561 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1826
Study 33032471 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis NLS super strain (B. infantis NLS‐SS)
Number of subjects: 12
Study 33032471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 35589595 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen combined with clopidogrel
Number of subjects: 152
Study 35589595 — intervention group
Group type: COMPARATOR
Intervention: Aspirin combined with clopidogrel
Number of subjects: 152
Study 33620407 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (50 to 150 mg per day)
Number of subjects: 314
Study 33620407 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 314
Study 34031109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) diagnosis
Number of subjects: 847
Study 34031109 — intervention group
Group type: COMPARATOR
Intervention: Integrated Management of Childhood Diseases implementation
Number of subjects: 847
Study 34269688 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention (ADvisor HP)
Number of subjects: 19
Study 32611648 — intervention group
Group type: EXPERIMENTAL
Intervention: Adavosertib (225 mg twice daily for 2.5 days/21-day cycle) plus carboplatin (AUC5) and paclitaxel (175 mg/m2)
Number of subjects: 121
Study 32611648 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus carboplatin (AUC5) and paclitaxel (175 mg/m2)
Number of subjects: 121
Study 33559338 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application (app) to monitor longitudinal electronic patient‐reported outcomes (ePROs)
Number of subjects: 191
Study 33559338 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination with smartphone app
Number of subjects: 191
Study 33559338 — intervention group
Group type: COMPARATOR
Intervention: Care coordination alone (control)
Number of subjects: 191
Study 32271919 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice
Number of subjects: 11
Study 32271919 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpeas
Number of subjects: 11
Study 32271919 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpeas plus rice (mixed meal)
Number of subjects: 11
Study 32271919 — intervention group
Group type: COMPARATOR
Intervention: l‐methionine (reference diet)
Number of subjects: 11
Study 34147554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-size Myval THVs (21.5, 24.5, 27.5 mm)
Number of subjects: 1115
Study 34147554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-size Myval THVs
Number of subjects: 1115
Study 33301991 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 180
Study 33301991 — intervention group
Group type: COMPARATOR
Intervention: Control (consult with FORCE exercise trainer, online exercise RT training program, resistance bands)
Number of subjects: 180
Study 33238961 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: chitosan
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: propolis 100 µg/ml (P100)
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: propolis 250 µg/ml (P250)
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: chitosan-propolis nanoparticle 100 µg/ml (CPN100)
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: chitosan-propolis nanoparticle 250 µg/ml (CPN250)
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: calcium hydroxide (CH)
Number of subjects: 240
Study 33238961 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) gel
Number of subjects: 240
Study 33658655 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 121
Study 33658655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 35426733 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program (75-min classes, twice weekly for 4 weeks, then once a week for 8 weeks, total 16 classes)
Number of subjects: 41
Study 35426733 — intervention group
Group type: COMPARATOR
Intervention: Educational film program (75-min classes, once weekly for 12 weeks, total 12 classes)
Number of subjects: 41
Study 32565388 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (control group)
Number of subjects: 514
Study 32565388 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus Denosumab (120 mg every 3–4 weeks)
Number of subjects: 514
Study 32565388 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with bone metastasis (subgroup analysis)
Number of subjects: 514
Study 32565388 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without bone metastasis (subgroup analysis)
Number of subjects: 514
Study 32565388 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events grade 3 or greater
Number of subjects: 514
Study 36180619 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative oral immunonutrition
Number of subjects: 62
Study 36180619 — intervention group
Group type: COMPARATOR
Intervention: Standard nutritional feeds
Number of subjects: 62
Study 34422262 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g sucrose in 500 ml water
Number of subjects: 12
Study 34422262 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 g sucrose in 500 ml water
Number of subjects: 12
Study 34422262 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 g sucrose in 500 ml water
Number of subjects: 12
Study 34087804 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal nicardipine
Number of subjects: 1351
Study 34087804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IT nicardipine)
Number of subjects: 1351
Study 33132093 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 55
Study 33132093 — intervention group
Group type: COMPARATOR
Intervention: Posterior Approach (PA)
Number of subjects: 55
Study 33132093 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches (DAA and PA)
Number of subjects: 55
Study 35675902 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia alone (MACSEVO)
Number of subjects: 6
Study 35675902 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with morphine (10 mg/kg) (MACSEVO+MOR)
Number of subjects: 6
Study 35675902 — intervention group
Group type: COMPARATOR
Intervention: Control group (no morphine)
Number of subjects: 6
Study 33687321 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine evaluation via audio-video conferencing
Number of subjects: 90
Study 33687321 — intervention group
Group type: COMPARATOR
Intervention: In-person evaluation by a clinician investigator
Number of subjects: 90
Study 33687321 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine evaluation
Number of subjects: 90
Study 33687321 — intervention group
Group type: COMPARATOR
Intervention: In-person evaluation
Number of subjects: 90
Study 32100031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics given to children
Number of subjects: 2157
Study 32100031 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic use among children
Number of subjects: 2157
Study 32100031 — intervention group
Group type: EXPERIMENTAL
Intervention: Average number of antibiotic courses per child
Number of subjects: 2157
Study 32100031 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics given without a prescription
Number of subjects: 2157
Study 32100031 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental knowledge of antibiotic indications
Number of subjects: 2157
Study 34078487 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Module promoting the Mediterranean Diet (MedDiet)
Number of subjects: 0
Study 34078487 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Module
Number of subjects: 0
Study 34847112 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinogoniometer measurement
Number of subjects: 31
Study 35383339 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day folate supplements
Number of subjects: 60
Study 33655789 — intervention group
Group type: EXPERIMENTAL
Intervention: RETRAINER + ACT
Number of subjects: 72
Study 33655789 — intervention group
Group type: COMPARATOR
Intervention: ACT
Number of subjects: 72
Study 32817266 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth home monitoring program (REACH) layered on usual care
Number of subjects: 219
Study 35435877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based breathing and music therapy
Number of subjects: 104
Study 35435877 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 104
Study 34328141 — intervention group
Group type: EXPERIMENTAL
Intervention: MYNd&CO intervention plus standard care
Number of subjects: 0
Study 34328141 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 32932009 — intervention group
Group type: EXPERIMENTAL
Intervention: Henna applied topically (n=30)
Number of subjects: 60
Study 32932009 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment and care (Control group, n=30)
Number of subjects: 60
Study 34545530 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal Cryo Nerve Block (CryoNB)
Number of subjects: 84
Study 34545530 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 84
Study 32162351 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic activity kit in addition to usual care
Number of subjects: 112
Study 32162351 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 112
Study 34247893 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-cane with 15-min walking training and 15-min traditional physical therapy (EG)
Number of subjects: 30
Study 34247893 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation without laser-cane (CG)
Number of subjects: 30
Study 34247893 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-cane (EG)
Number of subjects: 30
Study 33143121 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble Fiber Dextrin (SFD)
Number of subjects: 43
Study 33143121 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study 33049489 — intervention group
Group type: EXPERIMENTAL
Intervention: CISSS scoring system
Number of subjects: 534001
Study 35222899 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary combined nondrug therapy
Number of subjects: 70
Study 35222899 — intervention group
Group type: COMPARATOR
Intervention: Conventional conservative treatment (control group)
Number of subjects: 70
Study 33524191 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + PCV
Number of subjects: 355
Study 33524191 — intervention group
Group type: COMPARATOR
Intervention: RT + TMZ
Number of subjects: 355
Study 32678772 — intervention group
Group type: EXPERIMENTAL
Intervention: One-wheeled wheelbarrow
Number of subjects: 0
Study 32678772 — intervention group
Group type: COMPARATOR
Intervention: Two-wheeled wheelbarrow
Number of subjects: 0
Study 32678772 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass surface
Number of subjects: 0
Study 32678772 — intervention group
Group type: EXPERIMENTAL
Intervention: Asphalt pavement
Number of subjects: 0
Study 37879803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 179
Study 37879803 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 179
Study 32822614 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (20 mg three times daily) added to pirfenidone (801 mg three times daily)
Number of subjects: 177
Study 32822614 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to pirfenidone (801 mg three times daily)
Number of subjects: 177
Study 32726513 — intervention group
Group type: COMPARATOR
Intervention: norm‐ITL (FIO2 = 21%)
Number of subjects: 13
Study 32726513 — intervention group
Group type: EXPERIMENTAL
Intervention: hyp‐ITL (FIO2 = 15%)
Number of subjects: 13
Study 35708690 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health promoters intervention
Number of subjects: 1851
Study 35708690 — intervention group
Group type: COMPARATOR
Intervention: Outreach as usual wait-listed controls
Number of subjects: 1851
Study 33557875 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35799106 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-channel elastomeric pump (Group D)
Number of subjects: 90
Study 35799106 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C) - PCA drugs only in the constant flow chamber with normal saline in the adjustable flow chamber
Number of subjects: 90
Study 32951121 — intervention group
Group type: EXPERIMENTAL
Intervention: Passiflora incarnata (500 mg)
Number of subjects: 200
Study 32951121 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 200
Study 32951121 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrina mulungu (500 mg)
Number of subjects: 200
Study 32951121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35428324 — intervention group
Group type: EXPERIMENTAL
Intervention: Baihu and Guizhi decoction (BHGZ) plus low-dose colchicine
Number of subjects: 102
Study 35428324 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus low-dose colchicine
Number of subjects: 102
Study 33475705 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine plus Irinotecan
Number of subjects: 0
Study 33475705 — intervention group
Group type: COMPARATOR
Intervention: Irinotecan monotherapy
Number of subjects: 0
Study 32245506 — intervention group
Group type: EXPERIMENTAL
Intervention: Database-screening tools for recruitment
Number of subjects: 24
Study 32245506 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service (SMS) or email reminders for retention
Number of subjects: 24
Study 32245506 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital tools in general
Number of subjects: 24
Study 35223519 — intervention group
Group type: EXPERIMENTAL
Intervention: PPA (paravertebral blocks and propofol general anesthesia)
Number of subjects: 1253
Study 35223519 — intervention group
Group type: COMPARATOR
Intervention: GA (sevoflurane and opioids general anesthesia)
Number of subjects: 1253
Study 33039635 — intervention group
Group type: EXPERIMENTAL
Intervention: Early prophylaxis (EP) within ≤48 hours after emergency department arrival
Number of subjects: 146
Study 33039635 — intervention group
Group type: COMPARATOR
Intervention: Late prophylaxis (LP) after >48 hours
Number of subjects: 146
Study 33039635 — intervention group
Group type: EXPERIMENTAL
Intervention: Early prophylaxis (EP)
Number of subjects: 146
Study 33039635 — intervention group
Group type: COMPARATOR
Intervention: Late prophylaxis (LP)
Number of subjects: 146
Study 33039635 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of pharmacologic VTE prophylaxis initiation
Number of subjects: 146